Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,881 | -7,988 | -12,245 | -4,892 | N/A |
| Depreciation Amortization | 27 | 27 | 27 | 16 | N/A |
| Accounts receivable | 7,500 | -7,500 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 478 | 299 | 845 | 665 | N/A |
| Other Working Capital | 1,876 | -4,644 | 752 | 739 | N/A |
| Other Operating Activity | -5,289 | 8,617 | 3,381 | -432 | 0 |
| Operating Cash Flow | $-10,289 | $-11,189 | $-7,239 | $-3,903 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -543 | -525 | -137 | N/A |
| Investing Cash Flow | $-25 | $-543 | $-525 | $-137 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11 | N/A | 10,469 | N/A | N/A |
| Debt Repayment | N/A | N/A | -114 | N/A | N/A |
| Common Stock Issued | 16,148 | 38,425 | 0 | 0 | N/A |
| Other Financing Activity | -132 | 0 | -997 | -341 | 0 |
| Financing Cash Flow | $16,027 | $38,425 | $9,358 | $-341 | $N/A |
| Beginning Cash Position | 32,627 | 5,934 | 4,340 | 8,721 | N/A |
| End Cash Position | 38,340 | 32,627 | 5,934 | 4,340 | N/A |
| Net Cash Flow | $5,713 | $26,693 | $1,594 | $-4,381 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,289 | -11,189 | -7,239 | -3,903 | N/A |
| Capital Expenditure | -25 | -543 | -525 | -137 | N/A |
| Free Cash Flow | -10,314 | -11,732 | -7,764 | -4,040 | 0 |